“Come and join efforts at the Nordic Rare Disease Summit in Stockholm 17th April to improve conditions for people living with a rare disease”, Roland Kurney, General Manager, Takeda Pharma.
Sign-up here: https://www.nrds2023.org/
On the 17th April 2023 we invite for The Second Nordic Rare Disease Summit which takes place in Stockholm. Decision makers, healthcare professionals, patient organizations, media, academia and life science companies will come together to elevate rare diseases as a priority area in the Nordic countries. The Summit is a platform for policy discussions and the exchange of good ideas. The Summit is arranged by Takeda Pharma with contributions from Alexion AstraZeneca Rare Disease, Novo Nordisk, and Sobi. Additional partners are Rare Diseases Sweden, Lif - the research-based pharmaceutical industry in Sweden, EURORDIS - Rare Diseases Europe, SBONN - a network of six umbrella patient organizations for rare diseases in five Nordic countries, EUCOPE - The European Confederation of Pharmaceutical Entrepreneurs, and EFPIA - The European Federation of Pharmaceutical Industries and Associations.
Please visit the webpage for further information and sign-up for our Summit newsletter. At the homepage an agenda and registration link can be found:
The Summit will also have virtual attendance possibilities.